Genelux Corporation (GNLX)
NASDAQ: GNLX · Real-Time Price · USD
2.530
+0.080 (3.27%)
Sep 30, 2026, 4:00 PM EDT - Market closed
Genelux Market Cap
Genelux has a market cap or net worth of $113.37 million as of September 30, 2026. Its market cap has decreased by -28.56% in one year.
Market Cap
113.37M
Enterprise Value
97.12M
1-Year Change
-28.56%
Ranking
Category
Stock Price
$2.53
ChartMarket Cap Chart
Since the IPO on January 26, 2023, Genelux's market cap has decreased from $141.69M to $113.37M, a decrease of -19.99%. That is a compound annual growth rate of -5.88%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2026 | 113.37M | -30.88% |
| Dec 31, 2025 | 164.02M | 103.78% |
| Dec 31, 2024 | 80.49M | -78.50% |
| Dec 29, 2023 | 374.31M | 164.17% |
| Jan 26, 2023 | 141.69M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Aardvark Therapeutics | 115.33M |
| Vivani Medical | 112.75M |
| Seer, Inc. | 112.41M |
| Cibus | 112.35M |
| Milestone Pharmaceuticals | 112.08M |
| OnKure Therapeutics | 111.77M |
| Rani Therapeutics Holdings | 108.17M |
| PolyPid | 107.86M |